Ann: Appendix 4C Quarterly Activity and Cashflow Reports, page-34

... and a reminder to everyone - that doesn’t mean there is an issue, it’s just the high-low strategy used for nearly all vitamins/supplements!

re the 4C: I was wondering if the high manufacturing costs are creating stockpiles for China or actually the US? if the US is looming, an announcement would get this rocketing like it did before imo.

Also, does anyone know the payment terms - presumably it is over 3 months, seeing as some revenues from Q1 haven’t come in as cash in Q2. Seems long or do we have someone owing us money who is struggling?

Or is it due to a complex agreement (with Coles) whereby we only get paid 30 days after they actually sell the stock?

Thanks